PCSK9 Targeting in the Management of Hypercholesterolaemia
It has long been established that elevated plasma concentrations of low-density lipoprotein cholesterol (LDL-C) are among the prominent contributors leading to the development of atherosclerotic plaques and, ultimately, cardiovascular disease. In the current era of optimal risk factor modification,...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2023-10-01
|
| Series: | European Medical Journal Cardiology |
| Online Access: | https://www.emjreviews.com/cardiology/article/pcsk9-targeting-in-the-management-of-hypercholesterolaemia/ |